| B-type natriuretic peptide utilization as an adjunct to management in a case of conjoined twins with pulmonary hypertension. | |
| | |
MedLine Citation:
|
PMID: 20085871 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
This article reports a case of pulmonary hypertension in 37-week-gestational-age, pygopagus conjoined twins where B-type natriuretic peptide (BNP) was used as a cost-effective and important tool to aid effective management. Pulmonary hypertension in neonates is associated with high morbidity and mortality and multiplies the challenge of caring for conjoined twins. BNP is a peptide hormone secreted by cardiac ventricles that have undergone stress related to ventricular filling, volume overload, and pressure. BNP is commonly used in adults to assess heart failure, but its utility is less established in infants receiving neonatal intensive care. In this case, BNP testing was used as an adjunct to standard assessments for rapid diagnosis which was critical to expediting appropriate treatment management for these high-risk patients. |
| | |
Authors:
|
Vladana Milisavljevic; Isabell B Purdy; Cindy Le |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Neonatal network : NN Volume: 29 ISSN: 1539-2880 ISO Abbreviation: Neonatal Netw Publication Date: 2010 Jan-Feb |
Date Detail:
|
Created Date: 2010-01-20 Completed Date: 2010-04-01 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8503921 Medline TA: Neonatal Netw Country: United States |
Other Details:
|
Languages: eng Pagination: 5-12 Citation Subset: N |
Affiliation:
|
David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Biological Markers
/
metabolism Diseases in Twins / metabolism*, therapy* Dose-Response Relationship, Drug Female Humans Hypertension, Pulmonary / metabolism*, therapy* Infant Natriuretic Peptide, Brain / metabolism* Treatment Outcome Twins, Conjoined* Vasoconstrictor Agents / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Biological Markers; 0/Vasoconstrictor Agents; 114471-18-0/Natriuretic Peptide, Brain |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Response to pemetrexed chemotherapy in lung adenocarcinoma-bronchioloalveolar carcinoma insensitive ...
Next Document: Retinopathy of prematurity: an example of a successful screening program.